Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for C3K5E4

Entry ID Method Resolution Chain Position Source
AF-C3K5E4-F1 Predicted AlphaFoldDB

No variants for C3K5E4

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for C3K5E4

No associated diseases with C3K5E4

5 regional properties for C3K5E4

Type Name Position InterPro Accession
domain Alpha-D-phosphohexomutase, C-terminal 373 - 443 IPR005843
domain Alpha-D-phosphohexomutase, alpha/beta/alpha domain I 3 - 134 IPR005844
domain Alpha-D-phosphohexomutase, alpha/beta/alpha domain II 166 - 253 IPR005845
domain Alpha-D-phosphohexomutase, alpha/beta/alpha domain III 257 - 366 IPR005846
conserved_site Alpha-D-phosphohexomutase, conserved site 95 - 104 IPR016066

Functions

Description
EC Number 2.7.7.59 Nucleotidyltransferases
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

2 GO annotations of molecular function

Name Definition
[protein-PII] uridylyltransferase activity Catalysis of the reaction: UTP + (protein-PII) = diphosphate + uridylyl-(protein-PII).
phosphoric diester hydrolase activity Catalysis of the hydrolysis of a phosphodiester to give a phosphomonoester and a free hydroxyl group.

2 GO annotations of biological process

Name Definition
nitrogen compound metabolic process The chemical reactions and pathways involving organic or inorganic compounds that contain nitrogen.
regulation of nitrogen utilization Any process that modulates the frequency, rate or extent of nitrogen utilization.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MPQVDPELFD RGQFQAELAL KASPIAAFKK AIRQAREVLD GRFRSGRDIR RLIEDRAWFV
70 80 90 100 110 120
DNILQKAWEQ FSWSEDADIA LVAVGGYGRG ELHPYSDIDL LILLDSADHE IFRDSIERFL
130 140 150 160 170 180
TLLWDIGLEV GQSVRSVDEC AEEARADLTV ITNLMESRTI AGPERLRQRM LEVTSTAHMW
190 200 210 220 230 240
PSKDFFLAKR AEQKARHHKY NDTEYNLEPN VKGSPGGLRD IQTILWVARR QYGTLNLRAL
250 260 270 280 290 300
AGEGFLVESE NALLASSQEF LWKVRYALHM LAGRSEDRLL FDHQRSIATL LGFEGEDAKT
310 320 330 340 350 360
SIESFMQQYY RVVMSIAQLS DLIIQHFEEV ILAPEDEAPP QPINSRFQLH DGYIEARNDN
370 380 390 400 410 420
VFRRTPFAML EIFVLMAQQP EIKGVRADTI RLLRENRHLI DDDFRNDIRN TSLFIELFKC
430 440 450 460 470 480
KIGIHRNLRR MNRYGILGRY LPEFGFIVGQ MQHDLFHIYT VDAHTLNLIK HLRKLQYTQV
490 500 510 520 530 540
SEKFPLASKL MAKLPKPELI YLAGLYHDIG KGRHGDHSEI GAVDAEAFCQ RHQLPLWDSR
550 560 570 580 590 600
LIVWLVQNHL VMSTTAQRKD LSDPQVIHDF AGIVEDETRL DYLYVLTVSD INATNPTLWN
610 620 630 640 650 660
SWRASLLRQL YTETKRALRR GLENPVDREE QIRRTQSAAL DILVRGGNDP DDVEQLWSQL
670 680 690 700 710 720
GDDYFLRHTA GDVAWHSDAI LQQPADGGPL VLIKETTQRE FEGGTQIFIY APDQHDFFAV
730 740 750 760 770 780
TVAAMDQLNL NIHDARVITS SSQFTLDTYI VLDTEGESIG DNPVRVKKIR EGLTEALRNP
790 800 810 820 830 840
DDYPTIIQRR VPRQLKHFAF APQVTISNDA QRPVTVLELS APDRPGLLAR IGGIFLEFDL
850 860 870 880 890
SLQNAKIATL GERVEDVFFI TDADNQPLSD PELCRRLQDA IVQQLSVTQE PGVELTRLTI